Sartorius Stedim Biotech S.A. (ADR)
General ticker "SRTOY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $21.2B (TTM average)
Sartorius Stedim Biotech S.A. (ADR) follows the US Stock Market performance with the rate: 29.0%.
Estimated limits based on current volatility of 2.0%: low 23.88$, high 24.85$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-04-04, amount 0.08$ (Y0.32%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [13.84$, 23.53$]
- 2025-12-31 to 2026-12-31 estimated range: [13.87$, 23.57$]
Short-term SRTOY quotes
Long-term SRTOY plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | €2,780.00MM |
| Operating Expenses | €2,409.40MM |
| Operating Income | €370.60MM |
| Non-Operating Income | €-151.40MM |
| Interest Expense | €158.90MM |
| R&D Expense | €144.10MM |
| Income(Loss) | €219.20MM |
| Taxes | €40.70MM |
| Profit(Loss)* | €175.10MM |
| Stockholders Equity | €3,986.60MM |
| Inventory | €684.90MM |
| Assets | €8,256.40MM |
| Operating Cash Flow | €815.10MM |
| Capital expenditure | €339.80MM |
| Investing Cash Flow | €-340.00MM |
| Financing Cash Flow | €84.90MM |
| Earnings Per Share** | €0.18 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.